First Tracks Biotherapeutics Secures $145 Million in Private Placement Ahead of Spin-Off

Leila Ahmed North America Legal Chronicle
Tagged:

Mintz has advised the placement agents on the deal. First Tracks Biotherapeutics, Inc., in connection with its planned spin-off from AnaptysBio, Inc. (Nasdaq: ANAB), has entered…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here